Skip to content
Screener

SI-BONE, Inc. SIBN Operating Cash Flow

Operating Cash Flow at other companies

Stryker logo
StrykerSYK
$1.26B+13.5%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$447.8M+18.4%
Globus Medical logo
Globus MedicalGMED
$209.74M+169%
Alphatec Holdings logo
Alphatec HoldingsATEC
$1.29M+126%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
-$7.31M-673%
Medtronic logo
MedtronicMDT
$2.57B+1.8%

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$834.07M+25.5%
Enterprise value$843.49M+26.4%
P/S+0.5×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: SI-BONE, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 5:03 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001459839-26-000056
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Prepaid expenses and other assets777494
Accounts payable2,098952
Accrued liabilities and other(5,640)(4,426)
Net cash used in operating activities(2,362)(4,911)
Cash flows from investing activities
Maturities of marketable securities46,13060,000
Purchases of marketable securities(51,285)(47,298)
Purchases of property and equipment(1,077)(2,072)

Item 1. Financial Statements

FAQ

What is SI-BONE, Inc.'s operating cash flow?
SI-BONE, Inc. (SIBN) reported operating cash flow of -$2.36M in Q1 2026.
How has SI-BONE, Inc.'s operating cash flow changed year-over-year?
SI-BONE, Inc.'s operating cash flow increased by 51.9% year-over-year, from -$4.91M to -$2.36M.
What is the long-term trend for SI-BONE, Inc.'s operating cash flow?
Over 2 years (2021 to 2023), SI-BONE, Inc.'s operating cash flow has grown at a -31.2% compound annual growth rate (CAGR), from -$39.53M to -$18.71M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about SI-BONE, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude